CLENE INC - WARRANT
CLENE INC - WARRANT
Acción · US1856341102 · CLNNW (XNAS)
Resumen Indicadores financieros
0,03 USD
-19,55 % -0,008 USD
NASDAQ (XNAS) · Precios actuales y gráficos en MoneyPeak
05.06.2025 15:45

Cotizaciones actuales de CLENE INC - WARRANT

BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XNAS: NASDAQ
NASDAQ
CLNNW
USD
05.06.2025 15:45
0,03 USD
0,04 USD
-19,55 %

Rendimiento

Día Semana Mes 3 meses 6 meses 1 año 5 años
0,00 % 17,15 % 3,55 % -19,75 % -17,69 % -35,80 % -54,14 %

Perfil de la empresa para CLENE INC - WARRANT Acción

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company's products also include CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease, such as COVID-19 and to provide immune support for symptom resolution. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.

Datos de la empresa

Nombre CLENE INC - WARRANT
Empresa Clene Inc.
Símbolo CLNNW
Sitio web https://clene.com
Mercado principal XNAS NASDAQ
ISIN US1856341102
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Mr. Robert Etherington MBA
Capitalización de mercado 26 Mio
País Estados Unidos de América
Moneda USD
Empleados 0,1 T
Dirección 6550 South Millrock Drive, 84121 Salt Lake City

Símbolos de cotización

Nombre Símbolo
NASDAQ CLNNW

Otras acciones

Los inversores que tienen CLENE INC - WARRANT también tienen las siguientes acciones en su cartera:
FASTIGHETSBOL.EMILSHUS B
FASTIGHETSBOL.EMILSHUS B Acción
FIDELITY NA.INF. 18/48
FIDELITY NA.INF. 18/48 Bono
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025